Skip to main content

Table 1 Characteristics of the patients

From: Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma

Variables

3D reconstruction (n = 25)

No reconstruction (n = 22)

P

Age (years)

60.4 ± 10.4

59.0 ± 9.9

0.906

Sex, male/female

14/11

14/8

0.595

Cirrhosis, n (%)

17 (68.0)

15 (68.1)

0.989

TBIL (mmol/L)

37.8 ± 40.9

30.3 ± 46.5

0.788

ALT (U/L)

45.9 ± 21.9

50.9 ± 25.2

0.783

Platelets (10*9/L)

163.0 ± 69.2

161.2 ± 72.6

0.836

ALB (g/L)

34.5 ± 5.5

34.1 ± 6.1

0.445

Prothrombin time (s)

15.7 ± 2.9

15.6 ± 2.5

0.343

CA19-9, n (%)

16 (64.0)

16 (72.7)

0.522

CEA, n (%)

12 (48.0)

13 (59.1)

0.447

Child-Pugh, n (%)

  

0.510

 A

9 (36.0)

10 (45.5)

 

 B

16 (64.0)

12 (54.5)

 

Number of tumor sites, n (%)a

  

0.820

 Single

4 (16.0)

3 (13.6)

 

 Multiple

14 (84.0)

15 (86.4)

 

PTCD

3 (12.0)

2 (9.1)

1.000

ERCP

1 (4.0)

1 (4.5)

1.000

  1. TBIL total bilirubin, ALT alanine aminotransferase, AST aspartate transaminase, ALB albumin, AFP alpha fetoprotein, PTCD percutaneous transhepatic cholangiodrainage, ERCP endoscopic retrograde cholangio-pancreatography
  2. aBased on preoperative CT and/or MRI